Virtu Financial’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-772
| Closed | -$22K | – | 1562 |
|
|
2023
Q3 | $22K | Buy |
772
+636
| +468% | +$18.1K | ﹤0.01% | 996 |
|
|
2023
Q2 | $12K | Buy |
+136
| New | +$12K | ﹤0.01% | 1330 |
|
|
2022
Q1 | – | Sell |
-11
| Closed | -$56K | – | 1489 |
|
|
2021
Q4 | $56K | Buy |
11
+2
| +22% | +$10.2K | 0.01% | 1315 |
|
|
2021
Q3 | $56K | Sell |
9
-11
| -55% | -$68.4K | ﹤0.01% | 1254 |
|
|
2021
Q2 | $189K | Buy |
+20
| New | +$189K | 0.02% | 1018 |
|
|
2019
Q3 | – | Sell |
-3
| Closed | -$54K | – | 1414 |
|
|
2019
Q2 | $54K | Sell |
3
-4
| -57% | -$72K | ﹤0.01% | 1204 |
|
|
2019
Q1 | $109K | Buy |
+7
| New | +$109K | 0.01% | 1105 |
|
|
2018
Q2 | – | Sell |
-8
| Closed | -$103K | – | 1968 |
|
|
2018
Q1 | $103K | Sell |
8
-53
| -87% | -$682K | 0.01% | 1569 |
|
|
2017
Q4 | $560K | Buy |
+61
| New | +$560K | 0.03% | 756 |
|